Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users
patent: 8 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 44 Mendeley

So far, Altmetric has seen 1 Guideline that references this research output.

Management of pancreatic cancer: capita selecta

Clinical guideline published by KCE (Belgian Health Care Knowledge Center) on 12 May 2017

KCE is an independent research centre that provides scientific advice on topics related to health care. The topics are generally asked for by the public authorities (Minister / Ministry of Public Health, NIHDI), universities, professional associations, etc.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.